Pay close attention to severe adverse effects of tumor necrosis factor blockers

Qingtong Wang, Wei Wei

Research output: Contribution to journalArticle

1 Scopus citations

Abstract

Tumor necrosis factor (TNF) blockers are promising therapeutic agents for patients with conventional therapy insensitive inflammatory diseases. Unfortunately, their use has been associated with an increased rate of malignancies, leukemia, psoriasis and other immune diseases. The U. S. Food and Drug Administration (FDA) is requiring stronger warnings in the prescribing information for TNF blockers. Healthcare Professionals should pay close attention to severe adverse effects of TNF blockers and drug safety.

Original languageEnglish (US)
JournalChinese Pharmacological Bulletin
Volume25
Issue number9
StatePublished - Jan 1 2009
Externally publishedYes

Keywords

  • Adalimumab
  • Adverse effect
  • Etanercept
  • Infliximab
  • Rational administration
  • Tumor necrosis factor blocker

ASJC Scopus subject areas

  • Pharmacology

Fingerprint Dive into the research topics of 'Pay close attention to severe adverse effects of tumor necrosis factor blockers'. Together they form a unique fingerprint.

  • Cite this